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ABSTRACT

The motivation for this research is the high prevalence experienced by divers of
carbon dioxide (CO2) issues and concerns throughout their lives. Additionally, CO2 is
naturally occurring, the product of oxidative metabolism, and is undetectable to human
senses. Current CO2 sensor or detection technology is limited to high-cost machines
such as arterial blood gas monitors and end tidal CO2 monitors, or more modern
technology relying upon bright lights which measure blood flow. The light technology is
notoriously unreliable and does not produce a very effective heart beat allowing a user
to detect minimal changes. Heart Rate Variability (HRV) is the change (or variability) in
the timing between each heartbeat. There are few previous studies on this subject, but
new research is being done on HRV now, and professional athletes are training using
HRV as a performance and health indicator. Initial indications show that HRV may
prove quite useful in detecting stress on the autonomic nervous system which is
affected by CO2.
The experimental methods we used were the following. The study population
included 15 males between the ages of 18 and 50 years old and excluded those with
pulmonary concerns, as identified by a physician, because of HRV confounding factors.
This University of South Florida IRB approved study had minimal risk and noted
numerous off ramps or stopping points to ensure subject safety. Each subject was
normalized with respect to the known drivers for HRV and then tested breathing four
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different breathing mixtures. Subjects breathed air as well as air containing 4% CO2, 5%
CO2 and 6% CO2 with air breaks in between each CO2 exposure to ensure no buildup of
CO2. After being informed by the initial results of this clinical research study, a standalone device with an HRV sensing mechanism using a 3 lead ECG and proprietary
software designed by the authors to manipulate the data collected and present it in a
novel methodology was developed at the system level. The ultimate goal was to detect
CO2 prior to the onset of hypercapnic symptoms. This novel system, including the
analysis algorithm, relies upon comparing successive heart rates and plotting them in
an ever-shifting time domain axis which creates a return plot map. Formulating an
ellipse encompassing the majority of the data and detecting a change in eccentricity of
that ellipse when a subject is breathing a different gas is the novel nature of the system.
Experimental results can be summarized as follows. The null hypothesis was that
the mean of the ratio of the standard deviation of the long axis of the ellipse as
compared to the standard deviation of the short axis of the ellipse would be the same
for both the air breathing data set and the worst case of the CO2 breathing data set. A
standard t score with a one tail t test was calculated. The t-value is 13.91. On a
student’s T distribution table with a 99.95% confidence interval and 28 degrees of
freedom, the t-value would have to be greater than 3.6 to be significant. The p-value is <
0.00001. The null hypothesis was rejected. The results of the study were statistically
very significant. The study clearly demonstrates a dramatic change in the plot given an
identical time period for air breathing and CO2 rich air being breathed. The minimum
change (or difference) in the ratio when breathing CO2 to breathing air was a difference
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of 1.32 which represents a 34% change in ratio. The mean change was 1.93 (48.4%)
with a 0.30 (5.9%) standard deviation.
In conclusion, while there are some known concerns and issues to overcome, the
results are very promising for this pioneering study. This initial cohort study
demonstrates that HRV monitoring is reproducible in our study group, did show a
statistical change in response to elevated inspired CO2, and correlates with CO2
monitoring by other means. This type of HRV monitoring can be easily added via
software upgrades to current ECG monitoring machines or manufactured as a standalone ECG/HRV monitoring device. This algorithm reduces the need for additional,
more expensive CO2 monitoring devices and arterial blood gas analysis. We further
propose that HRV analysis can potentially provide an early warning system to detect
hypercapnia related symptomatology prior to escalation of symptoms to a detrimental
level and perhaps damaging or irreversible state.
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CHAPTER 1: INTRODUCTION
Carbon dioxide (CO2) is a colorless and odorless gas; although at very high
concentrations it can have a sharp or acidic odor. At standard temperatures and
pressures, the density of carbon dioxide is around 1.98 kg/m3, which is about 1.67 times
that of air. Under most normal conditions CO2 is undetectable to humans from visual,
olfactory and glossopharyngeal standpoints. CO2 is the byproduct of oxygen (O2)
metabolism in vertebrates, and present in higher concentrations in many naturally
existing areas on earth such as volcanos, hot springs and geysers. Given the
hazardous nature of the gas in high concentrations, and the fact that humans actively
produce it, special consideration should be given for the ability to detect CO2 prior to the
onset of harmful physiological symptoms.
Heart rate variability (HRV) has been put forth by many including McCraty and
Shaffer, of the Center for Applied Psychophysiology, at Truman State University as an
indicator of cardiovascular health [1]. A basic definition of HRV is the change (or timebased variation) in frequency intervals between adjacent heartbeats. The QRS complex
is a visual depiction of the human heart beat seen on a typical electrocardiogram (ECG,
EKG). The QRS complex corresponds to the depolarization of the ventricles (both right
and left) of the human heart and contraction of the ventricular muscles. These
electrophysiological waveform deflections are visually shown as spikes which appear in
rapid succession and reflect a cardiac cycle. A Q wave is a downward deflection
immediately following the P wave. R waves follow the Q as an upward deflection, and
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the S wave is a downward deflection after the R wave. For the purposes of timing a
cardiac cycle, the peak-to-peak interval, or heart rate, is commonly measured from one
R peak to the next R. HRV has been known to be related to the health of some of the
body's regulatory systems. For example, sympathetic and parasympathetic systems
affect chronic variations seen in HRV. Specifically, McCraty and Shaffer emphasized
that, "An optimal level of HRV within an organism reflects healthy function and an
inherent self-regulatory capacity, adaptability, or resilience [2]." Generally speaking, the
greater the HRV the better the health of the individual and less physiological stress.
Decreasing HRV indicates a possible pathology or poor function in levels of the selfregulatory control systems and could predict numerous risk factors [3].
The goal of this dissertation is to design and test a system that can monitor the
QRS complex and discern frequency variability or HRV by detecting the R and the R+1
(or successive R) temporal intervals at high temporal resolution. The generalized
dissertation rationale is that an acute metabolic condition related to elevated CO2 serum
levels will induce a decrease in heart rate variability thereby making this condition
detectable prior to symptoms being felt by the patient, or causing any type of permanent
physiological or anatomical damage.
This system will have sufficient power to operate for periods up to 24 hours and
collect the required data for real-time display as well as data analysis. We hypothesize
that HRV can be used to analyze and detect changes in physiological stress conditions,
and that it will be useful for detection of hypercapnic states in a variety of medical and
healthcare environments. The connected background calculations will feature a
Poincaré plot or “return map plot”. These plots can be used to distinguish physiological
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stress from background noise or chaos by embedding a data set into a higherdimensional state space. The plots will feature a time series of the form R at any time (t)
= Rt and the next successive R = Rt+1. This return map will plot (Rt, Rt+1) first, then it
plots (Rt+1, Rt+2), then (Rt+2, Rt+3), and so on. This tool can accurately detect variability
between two sets of time domain data consecutively by using a correlation analysis. Of
course, a higher correlation coefficient indicates decreased HRV, an indication of
dysfunctional self-regulatory control systems. The intellectual merit of this activity is
significant because this is the first-ever system to alert a user to indicate HRV pathology
or poor function, for various levels of self-regulatory control aspects of the
cardiovascular system.
1.1 Motivation for Research
This dissertation project’s prime motivation was to develop an autonomous
simplified system to determine shifts in HRV which are trending towards decreasing
variation, which indicate a pathology or poor function in various levels of self-regulatory
control systems just prior to subject discomfort, and the onset of signs or symptoms of
hypercapnia. As stated above, CO2 is a colorless and odorless and a problem when in
enclosed spaces. Additionally, while serving on active duty in the U.S. Navy, the author
experienced hypercapnia while diving a closed-circuit oxygen rebreather and at least
one person was reported as having succumb to hypercapnia while diving.
Symptoms and signs of early hypercapnia include flushed skin, increased pulse
pressure, tachypnea, dyspnea, premature contraction of the heart, myoclonic twitches,
asterixis, headache, confusion and lethargy. In cases of severe hypercapnia,
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symptomatology progresses to disorientation, panic, hyperventilation, convulsions,
unconsciousness, and possibly death.
In common medical practice, two such modalities are utilized, end tidal CO 2
(EtCO2) measurement during respiration, and arterial blood gas (ABG) sampling. These
modalities monitor serum CO2 through direct or indirect methods; however, they do not
identify impending pathological responses to the hypercapnia. Humans respond
differently to hypercapnia and as such some individuals are able to withstand higher
levels of CO2 without significant consequence. Our critical assessment of previous
research led to our hypothesis that HRV is a monitorable physiological biomarker that
can predict the onset of pathological hypercapnia, which is not measurable by the
current standard-of-care methods of EtCO2 and ABG.
For Self-Contained Underwater Breathing Apparatus (SCUBA) divers, CO2
buildup has been a known, serious, recurring and long-term cause of maladies.
Hypercapnia in SCUBA divers can lead to simple symptoms such as headaches or
cause profound symptoms such as loss of consciousness or drowning and death. In
diving, CO2 exacerbates the symptoms of Nitrogen Narcosis and is known to have more
severe narcotic effects than nitrogen alone due to the lipid solubility of CO2. So, in open
circuit SCUBA diving, monitoring of CO2 is important with respect to narcosis. In
rebreathers, CO2 must be removed from the breathing system, usually by a scrubber
containing a solid chemical compound with a high affinity for CO2, such as soda lime. If
not removed from the system, CO2 may be re-inhaled, causing an undesirable increase
in the inspired CO2 concentration. Failure, channeling or bypass of the scrubber
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canister can lead to rapid, possibly exponential, increases in CO2 and can have
compounding and serious detrimental biological effects.
Some diving system designs force a “dead space” which does not allow all of the
CO2 to escape to the environment. An example of this would be an elongated snorkel
device which will extend out of the water but never be fully evacuated because of its
design length. Another way a diver can experience an increase in CO2 is over-breathing
or over-exercising. Over-exercising produces excess CO2 due to elevated metabolic
activity, often in the face of voluntary hypoventilation to preserve breathing gas, thereby
rapidly increasing CO2 inspired concentrations. The density of all breathing gas is
higher at lower depths, so the effort required to fully inhale and exhale is increased,
making breathing more difficult and less efficient. The higher gas density also causes
gas mixing within the lung to be less efficient, thus increasing the dead space. Even
with normal respiration, SCUBA divers may experience alveolar hypoventilation
resulting in inadequate CO2 elimination or hypercapnia. Additionally, rapid descent rates
by divers can have similar impacts because the divers are unable to effectively remove
CO2 from their lungs due to rapidly increasing pressure on the lungs and incomplete
exhaust from the lungs. Finally, and perhaps most importantly, CO2 buildup hastens the
onset of CNS O2 toxicity and the synergistic effects of the two gasses in combination is
significantly more damaging than either gas alone. [4]
1.2 Limitations of Current CO2 Detection Technology
Current medical CO2 sensors range from $1,000 to $3,000 and up. Mass
spectrometers are much costlier and require considerable calibration and maintenance
to run effectively. Most medical CO2 detectors in hospitals or clinics rely upon costly
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disposable sensors and must sample the patient's expired breath in order to be
effective. These sensors measure end-tidal CO2 in expired air, which unfortunately does
not discern if the level of CO2 is problematic within a particular patient or diver in realtime; so not in line with current movements towards personalized medicine in health
care. A low-cost and effective alternative is needed to be able to identify hypercapnia
early and quickly prior to the onset of CO2 related symptoms within patients or divers.
Some diving equipment manufacturers have introduced CO2 sensors, but they
suffer from the same problems as medical sensors because they can only determine
inspired CO2 amounts. This is only partially helpful as CO2 affects people at different
thresholds. Alternatively, manufacturers have developed temperature sensing devices
within the CO2 scrubbing materials which can determine if the exothermic reaction is
propagating toward the end of life of the material, giving the user a possible indication of
CO2 breakthrough (or a predictor of hypercapnia), however this type of a sensor does
not indicate if CO2 is problematic for a particular person in real-time.
Some manufacturers have attempted to use a laser or infrared sensors and a
sensing pad to analyze CO2 for inhaled and exhaled breaths. These nondispersive
infrared sensors rely on the optical path to measure the concentration of CO2. Water
vapor can condense on the optical elements of the sensors blocking the signals the
sensors use, resulting in faulty CO2 readings. In sum, no portable, cost-effective device
or system exists today which can provide accurate early detection of hypercapnia as it
becomes problematic in a patient.
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1.3 Previous Studies on this Subject
A literature review suggests that HRV has been described by many as an
indicator of cardiovascular health [3]. HRV is the change or temporal variation in
frequency intervals between adjacent heartbeats. Sympathetic and parasympathetic
systems have been shown to affect these temporal variations [5].
An optimal level of HRV within an organism reflects healthy function and an
inherent self-regulatory capacity, adaptability, or resilience. Generally speaking greater
HRV is an indicator of better health and less physiological stress [3]. Decreasing
variation indicates a pathology or poor function in levels of self-regulatory control
systems [5,6].
Previous reports have demonstrated the power of HRV as a predictor of chronic
diseases such as COPD [7] as well as its insights into adequacy of autonomic
compensation to severe trauma [8]. The present study was performed to evaluate if
HRV will decrease in response to acute hypercapnia and develop and test a novel
device to provide early detection of carbon dioxide (CO2) related symptoms before the
onset of detrimental or permanent health effects in humans.
There are very few studies evaluating HRV and its clinical applications [9]. HRV
analysis has been used to monitor fetal distress in conjunction with Neonatal Critical
Care, as well as the effects of exercise training on HRV in patients with hypertension.
There are a number of reports of HRV analysis during surgeries and related to several
other chronic medical/surgical conditions [9]. None of these studies have focused on the
biomedical engineering aspects of developing and manufacturing a purpose-built HRV
monitoring and alert system for early detection of dangerous levels CO2. While there are
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myriad scholarly articles in exercise physiology, few if any relate to CO2 and HRV realtime analysis and detection systems.
Finally, Pöyhönen and colleagues added CO2 to inspired gas and showed that
this increased High Frequency (HF) and Low Frequency (LF) components of HRV in
normal ventilation conditions. [10] Breathing frequency is known to alter HRV
independent of partial pressure of CO2 (PaCO2). They further went on to discuss the
effect of PaCO2 appears to be related to levels of consciousness. This suggested a
modulation of the autonomic nervous system (ANS) activity would contribute to the
effects of PaCO2 on HRV [10] showing some promise as an example of research which
has in part inspired the present dissertation project.
The fact that attempts at conscious control of breathing frequency had no
significant effect on HRV [11], and that nonlinear HRV analysis using short term ECG
can be effective to detect real-life stress condition [12] makes HRV a perfect
determinate for ANS health because HRV cannot be consciously influenced by the
subject.
Poincaré Plots have been used in the past and in some ways shown a
relationship among LF, HF, length, and width [13] of the plot. However, no current
literature indicates that researchers are using the Poincaré Plots to detect acute stress
by using an ellipse fitting algorithm, and comparing a ratio of the standard deviation of
the short axis to the long axis.
1.4 HRV Background
HRV has been predicted and interpreted by using ECG waveforms. Generally
speaking the ECG test records the electrical activity of a human heart through small
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electrode patches that are attached to the skin of the arms, legs and chest. ECGs are
quick, safe, and painless and often used as a diagnostic test for checking heart rhythm,
see if there is poor blood flow to your heart muscles (called ischemia), to diagnose a
heart attack and to check on things that are abnormal, such as thickened heart muscle.
In this case the ECG is very reliable for determining the QRS complex and accurately
depicting the exact timing of each successive R peaks as pictured in Figure 1.1. For the
purposes of this project the amplitude of the R peak was ignored and only the timing
was used. The R was chosen because it is the steepest / sharpest change in amplitude
and therefore the easiest to detect.

Figure 1.1: Standard 12 Lead ECG
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The objective was to develop a device and an algorithm that can detect a shift in
HRV and use it as a predictor of a change in patient health prior to detectable
symptoms or permanent problems. Since HRV is a predictor of physiological changes in
the human body, we believe continually monitoring HRV could forewarn users of
impending physiological issues signifying a change in overall physiological health.
As previously discussed, HRV is the change or temporal variation in frequency
intervals between adjacent heartbeats as pictured in figure 1.2. The HRV measurement
was accomplished by analysis of the standard electrocardiography QRS complex
tracing. Detecting the time between the two successive R peaks (Rt, Rt+1and the time
between the next two R peaks (Rt+1, Rt+2)). This HRV measurement algorithm was used
here-in to analyze and detect changes in potential physiological stress conditions such
as hypercapnic states. This was accomplished using a modified Poincaré plot or “return
map plot”.

Figure 1.2: Drawing of a Waveform Representation of Temporal Variance of Frequency
Intervals Between Adjacent Heartbeats.

This return map plots as coordinates (Rt, Rt+1) then (Rt+1, Rt+2), then (Rt+2, Rt+3),
and so on. This analytical tool can be used to accurately detect variability between two
consecutive time domains using a correlation analysis. Higher correlation coefficients
indicate less variability and are a sign of dysfunctional self-regulatory control systems
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[4]. As shown in Figure 1.3, the line representing the standard deviation of the short axis
(SD1) and the line representing the standard deviation of the long axis (SD2) are in a
ratio of approximately 4:1 on the left side, which represents a normal R-R ellipse. In a
distressed R-R ellipse, pictured on the right of Figure 1.3, the ratio can be as little as
1:1. These plots along with an ellipse fitting algorithm were used to distinguish stress
from chaos by embedding a data set into a higher-dimensional state space. The change
in eccentricity of the ellipse is how the algorithm was able to track and predict
physiological distress.

Figure 1.3: Drawings of Poincaré Plots with Pictorial Representation of the Ellipse Fit
Algorithm with Short-axis Standard Deviation (SD1) and Long-axis Standard Deviation
(SD2) Marked on Both a Normal R-R Ellipse (left) and an Assumed Representation of a
Distressed R-R Ellipse (right). See Text for Further Axis Unit Definitions.
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CHAPTER 2: EXPERIMENTAL DESIGN
The study’s purpose was to determine if shifts in HRV which are trending towards
decreasing variation (potentially indicative of pathology or poor function in various levels
of self-regulatory control systems) would appear prior to subject discomfort and the
onset of more severe signs or symptoms of hypercapnia. The crossover design study
helped to answer the research question, “Can HRV be used to predict hypercapnia prior
to physical symptoms or accepted clinical signs of hypercapnia?”.
The N of 15 human subjects was selected as a proposed N for purposes of
collecting initial, preliminary data for proof-of-concept. Since this type of study has not
been completed before, we have no similar previous data upon which to perform a
power analysis. These initial data will provide the necessary information to provide a
power analysis for follow-up investigations.
2.1 Study Population Inclusion and Exclusion Criteria
Inclusions were male subjects 21-50-years (a normally distributed group, N=15)
were recruited by the International Board of Undersea Medicine for this study by Joseph
Dituri per USF IRB guidelines for acceptable and recruitment methods. Exclusions were
all female subjects; subjects with respiratory health problems as measured by vital
capacity; subjects with any physiological conditions or abnormalities; as well as any
condition the supervising physician excludes;
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Variations in female hormone levels associated with menstrual cycles in this age
group have a possibility of impacting HRV values, therefore females were excluded
from this initial study. On the physical exam, if a potential subject breathing
insufficiency was detected, i.e., insufficient vital capacity, the subject was excluded.
Also, major health problems involving the respiratory system would have been excluded
from this initial study. No subjects from the proposed group met the exclusion criteria
therefore none were excluded.
2.2 Potential Study Risks
This study was approved by the Institutional Review Board (IRB) at the University
of South Florida [CR1_Pro00030609] as shown in Appendix F. Minimal risk was
associated with the sticking pad, which may cause irritation for the ECG electrodes.
Additionally, fasting may cause dizziness or lightheadedness. Mild hypercapnia
symptoms can include headache, confusion and lethargy. Hypercapnia can induce
increased cardiac output, which will decrease HRV as well as induce an elevation in
arterial blood pressure and increase in arrhythmias. Symptoms and signs of early
hypercapnia include flushed skin, full pulse, tachypnea, dyspnea, premature contraction
of the heart that is independent of the normal rhythm of the heart, muscle twitches, hand
flaps, reduced or abnormal neural activity, and oftentimes a raised blood pressure. In
severe hypercapnia symptomatology progresses to disorientation, panic,
hyperventilation, convulsions, and unconsciousness. Hypercapnia is generally caused
by hypoventilation, lung disease, or diminished consciousness, but as described later
could be hastened by CO2 scrubbing system failures, rapid diving descents and
increased partial pressure of gasses.
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A medical doctor with extensive experience in hyperbaric conditions, USF
Assistant Professor Dr. Farhan Siddiqi, was present during all testing and a crash cart
was readily available, along with O2 along with necessary resuscitation equipment was
in place in the unlikely event it was required. Dr. Siddiqi was trained in the use of these
devices and had the capacity to affect a rescue or resuscitation, but it was not required.
All patients were monitored continually for flushed skin, dizziness, rapid breathing,
increased blood pressure, increased heart rate as well as muscle twitches and any
other potential malady which could be attributed to hypercapnia.
2.3 Off Ramps or Stopping Points to Ensure Subject Safety
If there was a recognizable shift in skin color, reported dizziness, 20% increase in
respirations or breathing pattern, 20% increase in blood pressure, 20% increase in heart
rate or any visible or reported muscle twitches, the subject would have been switched to
air regardless where they were in the protocol and observed until their end tidal CO2
goes below 40 torr. The physician would then perform a full physical examination
immediately to ensure the health of those individuals with any symptoms. If an off ramp
was observed, this subject would have been terminated and results noted. The
participants were all asked for to provide a “GO” or “NO GO” response every other
minute and the results were recorded. Each subject was instructed to end the
experiment at any time should they not feel comfortable by giving the NO GO sign. An
additional "off ramp" shall be if a change in HRV is detected specifically a greater than
50% change in the ratio of mirrored access in relation to the short access of a Poincaré
plot (normally a ~3:1 difference). An example would be a 50% change from ~4-1 to
~2:1.
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Additionally, if greater than 3 subjects experience an “off ramp” or “stopping
point” event, the study would have been stopped for a potential risk vs reward
evaluation.
Data collection was performed at the International Board of Undersea Medicine
(IBUM) building at 701 N. Westshore Blvd., Tampa, FL 33609, using a standard 12-lead
ECG for the purpose of detection of HRV anomalies with varying levels of CO2 breathed
by individuals and to determine if HRV can predict carbon dioxide increases prior to
hypercapnia symptom onset.
A series of gases were purchased from Air Liquide with verified contents of 6%
5% and 4% CO2. Each contained 21% O2 and the remaining portion (balance) was
nitrogen. These three separate gas amounts were cascaded into individual SCUBA
cylinders containing the same contents in smaller, more maneuverable cylinders. Each
cylinder contained between 2000 Pounds Per Square Inch (PSI) and 3000 PSI. A fourth
SCUBA cylinder containing only air (21% O2 and 79% nitrogen) from a grade E certified
pure compressor was used.
The four SCUBA cylinders were connected to four different Hollis and Poseidon
Deutsches Institut für Normung (DIN) first stage regulators. The gas pressure was
reduced from between 2000 PSI and 3000 PSI to approximately 135 PSI. The low
pressure lines from each individual regulator were cascaded into a common manifold.
A single second stage regulator was connected as an outfall from the common manifold
and routed to the test subject’s mouth. Each SCUBA cylinder was carefully labeled with
content decals and properly ordered such that no mistakes were made during the
administration of gas to the subjects.
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The exhaust from the second stage regulator was directed to a half inch hose
which was connected to a Smiths Medical Capnograph (Model 8400) for sampling of
end-tidal CO2. The exhaust was further directed into the intake of the air conditioning
system in the facility to direct and distribute the carbon dioxide ladened exhaust away
from the subject and staff performing the research. The subject’s pulse oximetry /
percent O2 was also monitored via a transcutaneous finger lead.
The subject was fitted with a Nasiff cardio resting (Model CUSB Rev A7) 12 lead
electrocardiogram using Fastrace ECG leads as seen in figure 2.3 below. The subject’s
entire cardiac cycles were monitored throughout the duration of the testing.

Figure 2.1: Visual Representation of a Study Subject.
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The entirety of the test was videoed using a GoPro Hero 5. The subject’s blood
pressure was taken using a Longs Drugs model BP 3AA1-1 every 5 minutes and
recorded on paper.
At least 48 hours prior to participation in the study, the participant underwent a
physical examination including a neurological assessment prior to being allowed to
participate in the study, and subjects with any physiological conditions or abnormalities,
including cardiovascular problems were excluded by our Study physician.
The overall duration of a study for an individual was in all cases less than 5 hours
total. All subjects were required to fast for 10 hours prior to ECG tests to minimize the
impact of metabolic differences on the subject’s HRV. All subjects were in good physical
health and were instructed not perform exercise for 10 hours prior to ECG tests.
Nicotine and caffeine were allowed during the study but not during the 10-hour
fast prior to the study. All subjects kept a lifestyles diary during the study with food
intake, nicotine intake, caffeine intake, drugs, sports or dietary supplements, alcohol
intake and any medications taken for 48 hours prior to the study period. Additional
entries were to be made in the diary concerning stresses experienced within 10 hours of
the study. During the fasting process water was acceptable.
The subjects all went through an identical intake process consisting of notification
of subject’s rights, discussion and signature of consent forms along with a relaxation
period. At the intake the time consent was re-affirmed by the participant. Subjects
entered into the testing room and laid upon the subject table in a dimly lit, silent room.
The study coordinator connected the ECG leads to the subjects and connect them to
the breathing apparatus which was set to deliver normal air.
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A 20-minute acclimatization period was afforded to accommodate those not
comfortable with the breathing device (if required) in order to standardize the protocol
and allow for adaptation in comfort levels. During that time, a baseline HRV was
established for each participant. Additionally the blood pressure and pulse was
monitored every 10 minutes during study. Familiarization with the chest breathing
apparatus device, as well as with environment where the tests were performed was
critical since these factors can modulate HRV biomarkers. It was important to make
sure that the subjects were as comfortable as possible with the experimental process
prior to taking the HRV measurements.
Prior to measuring HRV, a 20-minute acclimatization period was observed with
low ambient room lighting, similar room temperature and no audible or visual
disturbances while connected to the ECG. The entire study was recorded with video
and audio settings to monitor and record any behavioral symptoms of CO2 toxicity. This
condition remained consistent during all subsequent testing throughout the entire study.
Individual test subjects served as their own control while they were exposed to air
during the data collection cycle. There were three 10-minute exposures to high CO2
breathing periods which are stepwise increased. Exposure levels of CO2 were 4%, 5%,
and 6%. The mixtures will be as seen in Table 2.1 below.
Each cycle started with a 20-minute acclimation period followed by a step wise
increased exposure to CO2 for 10 minutes followed by a 20 min breathing air (recovery
period) or until ETCO2 goes below 40 torr or complete CO2 washout to ensure
reversibility followed by another 10 min breathing of a predetermined mix to assess
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post- CO2 HRV. This continued for four cycles of breathing all the gasses listed in Table
2.1 in a stepwise increasing CO2 exposure order.
Table 2.1: List of Gasses and Quantities
Oxygen %

Nitrogen %

Carbon Dioxide %

Mix 1

21

79

0

Mix 2

21

75

4

Mix 3

21

74

5

Mix 4

21

73

6

2.4 Human Subjects Considerations
Description of the informed consent process: At least 48 hours before any
experimental procedures subjects were interviewed and presented with all study
materials and consent forms to review in detail with the Study Coordinator and
physician. Upon arrival on day of study they re-affirmed their desire to consent.
Discussion of how the privacy and confidentiality of the subjects was maintained:
The paper file for each subject is stored in a locked file cabinet. All computer data files
are password protected.
This is viewed as a minimal risk study in that similar carbon dioxide percentages
exist in the normal method for saving lives such as Cardio Pulmonary Resuscitation
(CPR). We used 10-minute exposures. Lambertsen, (1971) established safe stay times
in CO2 and we are only slightly above one of those for shorter durations. [14]
Lambertsen recommends a safe stay time of 6% for a period of 30 minutes, consistent
with our use of 6% at 10 minutes to elicit a hypercapnia symptom and physiological
response. The present study is low risk for three 10-minute exposures to 4%, 5% and
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then 6% with adequate direct physician supervision and adequate "off-ramps" at the first
indication of any signs of hypercapnia. Lambertsen states that still higher concentrations
should be respirable for many hours without acute harm or residual effects.
2.5 Specific Contribution to the Field
This project will advance discovery and understanding while at the same time
promoting learning by demonstrating a correlation between HRV and common stresses
within the body such as hypercapnia. The results of the project will be disseminated
broadly to enhance scientific and technological understanding. The potential benefits of
this research, to society at large, are innumerable in that this physiological measuring
system can be used external to the body with non-invasive technologies, yet can
potentially detect and warn against a number of serious, internal physiological lifethreatening conditions. Some conditions proposed along with hypercapnia are COPD,
MDS/anemia, Decompressive Stress and Oxidative Stress.
The intellectual merit of this proposed activity is significant because this would be
the first ever designed device to alert a user to indicate a pathology or poor function in
various levels of self-regulatory neural control aspects of the cardiovascular system. A
USF patent was filed for a system which is described below and meets the
shortcomings and limitations identified above.
2.6 Device Design
The system which was used to collect the data for the human subject study took
an analog signal from a commercially available ECG machine which ported out the R
time interval for each successive heartbeat. This signal was fed via a 3-conductor 1/4"
Phone Plug into an MSP430F5529 Texas Instruments LaunchPad (pictured in figure 2.2
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below) which allowed the signal to be converted from analog to digital, and a program
written in Python for ease of display and data analysis.

Figure 2.2: MSP430F5529 Texas Instruments LaunchPad and Phone Plug
Foremost for the final device design, the Python program in Appendix A needed
to be converted to the C programming language. Initial application for a provisional
patent was applied for during cultivation of the idea and manufacturing of the prototype.
Following the one-year period for provisional patent, a utility patent has been applied for
by the author and the University of South Florida Technology Transfer Office.
The purpose of this prototype system was to realize the python algorithm
engineered by the author on an embedded platform, and to better understand the
hardware implementation and requirements. For instance, the python implementation
provides a file containing the times associated with the measured ECG R peaks.
For prototyping purposes, we used a commercial off-the-shelf single lead ECG (3
electrodes) monitor board. The monitoring board uses ANALOG DEVICES Single-Lead,
Heart Rate Monitor Front End device, AD8232. The AD8232 is an integrated signal
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conditioning block for ECG and other biopotential measurement applications. It is
designed to extract, amplify, and filter small biopotential signals in the presence of noisy
conditions, such as those created by motion, muscle movements or remote electrode
placement. This design allows for an ultralow power analog-to-digital converter (ADC) or
an embedded microcontroller to acquire the output signal easily. The AD8232 can
implement a two-pole high-pass filter for eliminating motion artifacts and the electrode
half-cell potential. This filter is tightly coupled with the instrumentation architecture of the
amplifier to allow both large gain and high-pass filtering in a single stage, thereby saving
space and cost. An uncommitted operational amplifier enables the AD8232 to create a
three-pole low-pass filter to remove additional noise. The user can select the frequency
cutoff of all filters to suit different types of applications.
To meet the 10 hours run time requirement for this device, a Lithium Ion Polymer
Battery 3.7V 2500mAh was chosen. With the entire Heart Monitoring box consuming
about 150mA, this battery should provide approximately 16 hours of run time
(2500mAh/150mA = 16h). There is a 500mA fast acting safety fuse installed to prevent
shocking risk. The battery charger selected is a USB LiIon/LiPoly Charger – v1.2. This
allows recharging via USB port and the fast-charge current is 500mA by default but is
easily adjustable from 100mA up to 1000mA. There are also separate JST connectors
for battery and load system, so the battery does not need to be removed during
charging.
The Heart Monitoring unit uses a Kinetis K66 microcontroller unit (MCU). The
MCU is a 32-bit 180 MHz Cortex-M4 processor. Due to the heavy calculations required
by this device, a normal 8-bit MCU would not suffice. Compared to an 8-bit processor,
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this MCU will fetch and write four times faster because of its 32-bit architecture. This
MCU also comes equipped with a floating-point unit (FPU, a math coprocessor), which
is necessary to perform non-integer math operations. Another requirement of the MCU
was a high-resolution ADC. The ADC is necessary to read the output signal of the
AD8232 device. The MCU ADC has a 10-bit resolution which means the lowest voltage
level that it can detect from the AD8232 is 3.3/2^10 = 3.3/1024 = 3.2mV. For ease of
prototyping, a Teensy 3.6 MCU development board was used. The development board
incorporates the Kinetis MCU. The development board also comes with 1 Megabyte
Programmable Flash. This flash size provides adequate storage for the application
firmware and supports future enhancements of the application firmware. Last, there is
an onboard micro SD card port for datalogging along with a USB port for programming
and debugging.
The Pan-Tompkins algorithm [15] was used for real-time detection of the QRS
complexes of ECG signals. This algorithm reliably recognizes QRS complexes based
upon digital analyses of slope, amplitude, and width. It has a digital bandpass filter to
reduce false detections caused by the various types of noise present in normal ECG
signals. The chain of filters run is a DC block, low pass @ 15 Hz and high pass @ 5Hz.
The filtered signal goes both through a derivative filter, which output is then squared,
and through a windowed integrator. This filtering permits use of low thresholds which
increases the detection sensitivity. The algorithm adjusts thresholds and parameters as
required to automatically adapt to ECG changes making it highly accurate for detecting
QRS complexes.
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The display is a 2.28” Thin-film-transistor liquid-crystal display (TFT LCD) with a
Serial Peripheral Interface (SPI). This was selected because only 4 pins are required to
communicate with the LCD and Arduino support makes for an easy code development
environment.
The box housing the components was 3D printed with ABS filament. The unit
has a pushbutton which is used to START and STOP a test. The unit also contains a
haptic motor which alarms if the ratio of HRV changes >25%. The LED toggles with the
detection of a QRS peak according to the Pan-Tompkins algorithm. The unit comes with
a USB interface which makes it convenient and fast to transfer data from the MCU to a
host PC for post processing and firmware updates.
The device had significant timing constraints which had to be allowed for and
compromises made. The MCU samples the AD8232 output signal (ECG data) at 1
KHz, which equates to a period of 1 millisecond (ms). It takes 56ms to update the TFT
LCD Screen and to store the latest datapoint to the SD Card. The time required to
calculate the math for the ratio of SD1 : SD2 is about 40 ms. The 1ms sampling period
is achieved with a timer callback function. When 1 ms has expired, a flag is set which
allows the Pan-Tompkins algorithm to retrieve a new sample. The benefit using a timercallback approach is that it does not block the execution of MCU and therefore it can
continue to process the RR ratio while waiting for the next sample. However, during the
LCD and SD Card update, the interrupts must be disabled to prevent interruptions in the
communication stream between the MCU and LCD and SD-card. It is important to note
that since the LCD and SD card update takes about 56 ms, 56 samples will be missed
during update. Since most individuals have between 500-1500 ms RR interval, this is
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not be an issue, however the LCD update must be programed to happen immediately
after a peak sample has been detected.
Firmware was development using the Arduino Integrated Development
Environment (IDE) version 1.8.6 and Teensyduino version 1.44. The following three
functions (panTompkins, time_average_rr_ratio, and calculate_rr) are responsible for
the realization of our new algorithm.
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CHAPTER 3: EXPERIMENT RESULTS

The human subject data set for this initial investigation consisted of twelve
Caucasian males, two Asian males and one black male. The age of subjects was a
mean of 38.7 years old with a standard deviation of 9.7 years. A careful review of the
daily food logs of each subject was conducted. Because this was an ex post facto
representation of their diet and the subjects were only told to record what was
consumed, there is little similarity between subject’s caloric intake or diet, and no
evidence of any correlation between diet and HRV changes were observed.
The data was recorded on a 12 lead off-the-shelf ECG. This ECG has a real-time
port which sends the R signal from the QRS complex out repeatedly. The new program
was written in C language and detailed in Appendix A took this real-time input and
processed it for visual representation of the data by plotting the R as (X,Y) coordinates
using the procedure of first plotting (Rt, Rt+1) then plotting (Rt+1, Rt+2), then (Rt+2, Rt+3),
and so on where t=time. The program in Appendix A afforded the research team the
ability to view the changes in HRV, associated with breathing different gasses, in real
time. This analytical tool was used to accurately detect variability between two
consecutive time domains using a correlation analysis. The program then computed the
SD1 and SD2 of the produced ellipse and compared them to each other in a ratio. The
program then represented the 1 minute, 5 minute and full duration average of the ratio
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for comparison of changes. As the ratio reduced, the visual representation
demonstrated the change of the HRV.
One hundred percent of the subjects displayed a detectable change in HRV.
None of the subjects showed any clinical symptoms of hypercapnia nor did any of them
request to terminate or were terminated for medical concerns by the attending
physician. Observations for confounding variables that could affect the HRV was
performed and there was no recognizable shift in skin color, dizziness change in
respiratory rate, blood pressure, or heart rate of subjects of greater than 20% in any
subject, cue to changes in HRV.
However, the changes in HRV associated with changing breathing gasses,
instead of shrinking and coalescing into a smaller circle as pictured on the right side of
figure 2.2 above, as we hypothesized initially, tended to expand the variability spread
into a larger circle. The SD of the short and long axis did converge and approach a 2-1
ratio or less, but instead of reducing the size of the plot, the size was increased. SD1
tended to increase its length as opposed to SD2 reducing its length. The net result is a
change in the ratio but not in a manner that was initially expected.
The null hypothesis was that the “mean of the ratio of the SD2:SD1 would be the
same for both the air breathing data set and the worst case of the CO2 breathing data
set.” The mean difference of the air breathing set (X-Mean= M1) was 3.99 while the
mean difference from the CO2 breathing data set MSD2:SD1 (Y-Mean= M2) was 2.06
while the square of the mean of air breathing set ((X-Mean)2 = SS1) was 2.61 and the
square of the mean of the ((Y-Mean)2 = SS2) was 1.44.
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A standard t score with a one tail t test was calculated. The t-value was 13.91.
The p-value was < 0.00001. The null hypothesis was rejected.

Figure 3.1: Demonstration of Changes in HRV When Breathing Air and CO2.
Subject side-by-side comparison HRV plot (left) on air and (right) after introduction of
higher concentration CO2. Both from subject on Feb 28th 2018.

A visual comparison (Figure 3.1 from our clinical research study) clearly
demonstrates a dramatic change in the plot given an identical time period picture for
both left (air) and right (CO2). A quantitative comparison shows a decrease from a 4.10 :
1 ratio to a 2.31 : 1 ratio of long axis to short axis. The results for Figures 3.2 and 3.3,
for two more representative subjects, are similar, starting from a subject’s baseline (air
breathing portion) on the left and a section of increased CO2 breathing on the right.
The full representation of the data is provided in Table 3.1 below. The minimum
change (or difference) in the ratio when breathing CO2 to breathing air was a difference
of 1.32 which represents a 34% change in ratio. The mean change was 1.93 (48.4%)
with a 0.30 (5.9%) standard deviation.
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Table 3.1: Full Data Showing Long and Short Axis of Ellipse Comparison and Ratios as
Well as Age of Subjects.
Subject Age Air ratio CO2 Ratio Difference % change Diff ^2
1
30
4.09
1.87
2.22
54.28
4.93
2
47
3.78
2.46
1.32
34.92
1.74
3
47
4.11
2.49
1.62
39.42
2.62
4
34
4.45
2.08
2.37
53.26
5.62
5
50
3.41
1.56
1.85
54.25
3.42
6
31
4.84
2.51
2.33
48.14
5.43
7
50
4.16
1.98
2.18
52.40
4.75
8
30
3.86
1.93
1.93
50.00
3.72
9
41
3.08
1.36
1.72
55.84
2.96
10
35
4.15
2.05
2.1
50.60
4.41
11
22
4.22
2.18
2.04
48.34
4.16
12
46
4.1
2.31
1.79
43.66
3.20
13
50
3.87
2.09
1.78
45.99
3.17
14
43
3.51
1.96
1.55
44.16
2.40
15
25
4.23
2.07
2.16
51.06
4.67
SUM
59.86
30.9
28.96
726.33
57.21
Mean 38.73
3.99
2.06
1.93
48.42
3.81
STD
9.68
0.43
0.32
0.30
5.90
1.15

Figure 3.2: Demonstration of Changes in HRV When Breathing Air and CO2.
Subject side-by-side comparison HRV plot (left) on air and (right) after introduction of
higher concentration CO2. Both from subject on March 2nd 2018.
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Figure 3.3: Demonstration of Changes in HRV When Breathing Air and CO2.
Subject side-by-side comparison HRV plot (left) on air and (right) after introduction of
higher concentration CO2. Both from subject on March 8th 2018.
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CHAPTER 4: DISCUSSION
It appears there is a clear difference in the Air and CO2 breathing conditions, as
well as for the quantitative, graphical representation of the data while breathing CO2. In
each case, the plots returned to near baseline once the subjects were removed from the
gasses rich in CO2 and the EtCO2 reduced below 40 torr. We have demonstrated that a
change in HRV is not only detectable but would be a good tool to display the stressrelated to breathing CO2 prior to the onset of significant clinical hypercapnic symptoms.
While the data are not as clear as our initial hypothesis purported, there is clearly a
discernable change in HRV using the Poincaré plot analysis and the modified ellipse
fitting algorithm by comparing the ratio of SD2:SD1 over multiple temporal iterations.
The data were analyzed in different ways and the ultimate useful data collection
was achieved iteratively. The most successful combination was to compare the 1minute, 5-minute and 10-minute ratio of SD2:SD1 for all data. Initial data collection
seemed to indicate an ANS response to a stress (in this case increased levels of CO2)
to occur within 2 minutes of switching gasses; so, suggestive of a response time of less
than 2 minutes. The running 1-minute, 5-minute and 10-minute ratio each continued and
moved in concordance. Specifically, the 1-minute ratio was the first part of the 5-minute
and 10-minute ratios as was the 5-minute ratio the first part of the 10-minute ratio, and
all ratios moved together in a first-in first-out methodology with respect to time. This
allowed the data analysis to capture the maximal change in ratio, as well as span the
entire gas change period which was limited to 10 minutes/CO2 concentration.
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Multiple groups of data were collected on each subject, including vital signs,
EtCO2, pulse oximetry, ECG and HRV as well as dietary and stress information from the
previous 48 hours via questionnaire. Vital signs including respirations, pulse and blood
pressure did not change more than 20% for any of the subjects, and often much less
than 20%. The reasoning for not investigating further into devices or systems which
could monitor vital signs was that type of monitoring usually impacts the subjects by
increasing their blood pressure due to the extra monitoring equipment applied to them.
Pulse oximetry had a minimal change of 2% overall and did not seem to correlate with
gas changes, making it ineffective for prediction of CO2 levels.
A review of the diet consumed did not reveal and contributing factors, as
expected. Since the subjects were to report any substance going into their body and not
instructed concerning exact intake, the results of caloric intake were wide and varying.
We believe we successfully mitigated the caloric intake as it pertains to influencing HRV
by not allowing any food (fast), caffeine or nicotine 10 hours prior to the study.
Consequences of food intake and metabolism fluctuations are not often recognized,
however, consumption of food and water followed by gastric distension and bladder
filling can directly impact HRV. Limiting food intake obviated this.
All of the subjects were requested to report any stress and/or stressful events in
their lives in the 48 hours prior to the testing. While no significant stressful events were
reported by any of the subject, minor daily stresses were reported. None of the subjects
reported being at all stressed in the 10 hours preceding the test, nor during the test.
The tests were all administered between the hours of 08:00 and 10:00 am. This
similar testing time should mitigate impacts due to differential restfulness and circadian
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rhythm and its impact on HRV. None of the subjects reported being “tired” or lacking
rest.
Each study participant was asked every 10 minutes throughout the study if they
were “feeling ok” and if they “wished to proceed”. In all cases the participants signaled
they wished to proceed with the study and that they were ok. Following the study, none
of the participants had adverse responses or regrets about the study as polled in their
exit interview.
Of all data collected, the most profound changes were observed during
hypercapnic test periods in EtCO2 and HRV SD2:SD1 ratio. Both EtCO2 and HRV
SD2:SD1 ratios changed by greater than 20%, in comparison to all other data groups.
EtCO2 monitoring is both expensive and requires a closed sampling of the expired gas.
However, HRV calculation is simpler to perform utilizing more readily available portable
ECG machines with the addition of a real-time software method of detection and
analysis such as that developed here. One method of calculating the change is to
develop an ellipse fitting algorithm which would remove obvious outliers in the data.
Once that ellipse is projected around the data, a program could calculate the length of
the short and long axis and compare it to the normal condition, as demonstrated in
Figures 3.1-3.3 above. The graphs represented in Figures 3.1, 3.2 and 3.3 are
representations of the computer program in Appendix A which was developed during
the study to interpret the HRV return map plot. Such a software addition to standard
ECG machines may offer the benefit of monitoring for hypercapnia-related HRV
changes without the need for the additional cost and maintenance of EtCO 2 monitoring,
and as such could be added to already existing ECG monitors in hospital or urgent care
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emergency departments, intensive care and pulmonary units, and to diver rebreather
equipment.
The initial hypothesis of this research and development dissertation project was
that the change in eccentricity of the ellipse fitted around the data would not increase
the SD1 but decrease the SD2 bringing it closer to a one-to-one ratio. This assumption
was predicated upon the initial HRV change data obtained from chronically ill patients.
Surprisingly, the results from the present acute study indicate that the SD1 increases by
as much as two times. Although the significant change in the responses due to the CO2
is noteworthy (as expected), The SD1 increase was not part of the initial assumption.
However, the standard deviation ratio of SD2:SD1 did in fact change as predicted. A
possible reason for this novel finding could be the body’s response to the stress
imposed on it by the CO2. CO2 in and of itself is a vasodilator for the smooth muscles.
As CO2 vasodilates, cardiac stroke volume increases which may have manifested the
different presentation of the variance changes in HRV for the acute experiment carried
out in the present dissertation.
We suspect that even given the increase in the SD1 by a significant amount that
we observed in our clinical research experiment, as demonstrated on the right sides of
figures 3.1-3.3 above, that if the exposure to CO2 continued for longer than the short
term acute durations of time used here, that the HRV would remain in a similar
“stressed ratio”, but would normalize and decrease in overall size to that commensurate
with other distressed predictions on the right side of figure 1.3. Prolonged exposure to
lower level amounts CO2 is a significant scientific and exploration obstacle on longduration saturation diving missions as well as interplanetary travel and on the
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International Space Station. The novel detection methodology developed in the present
dissertation bears significant credibility for carbon dioxide detection in chronic states as
well, although the changes due to elevated CO2 appear to be different for acute vs.
chronic physiological states.
Given that HRV is predictive of a stressed ANS, there is a possibility that our new
systems and novel detection methodology could be predictive of other serious healthrelated maladies. For instance, the ANS is stressed immediately preceding an epileptic
seizure. Since the mechanism of action in epilepsy is similar, not only could this be used
to sense an impending seizure before it starts, i.e., an early warning for an epileptic
seizure, but it could also be used to warn a diver of CNS O2 toxicity seizures associated
with breathing hyperoxic gas mixtures. Since many undersea deaths have been blamed
on CNS O2 toxicity this science could lend itself well to saving lives. Contrary to CO2, O2
is a vasoconstrictor. Because there is a possible use for this device to detect CNS O2
toxicity and seizures, many tests would need to be conducted and the outcomes
assessed to better understand the body's response to physiological stress and changes
in HRV.
4.1 Known Concerns and Issues to Overcome
We acknowledge that HRV monitoring can be affected by several confounding
factors. These factors include but are not limited to: sex, nicotine intake, caffeine intake,
several over-the-counter drugs, some prescription drugs, hormone levels, the presence
of oxidative stress, age, body mass index, depression, psychological stress, physical
activity levels and race [16,17]. HRV is also broadly impacted by cardiovascular,
vasoactive and psychotropic medications, circadian rhythms and wakefulness. Less
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frequently recognized are the consequences of food intake and metabolism fluctuations.
For example, it has been determined that the acute consumption of food and water,
gastric distension and bladder filling can affect HRV [18]. For these reasons it is
important for all users to become their own control in the use of this device. Gathering a
consistent baseline calibration where-in a proposed device could “learn” the users
predicted “normal” operating ellipse during a given exercise or activity, and then show a
delta given the introduction of a specific pathology or stressor, are quite important
experimental design features for clinical and commercial systems to be developed now.
While the results of the present experiment seem to be quite promising, it is
evident that the data represent an initial positive outcome and bears further testing and
development. Due to the stationary nature of each subject and the controlled
environment, additional studies would be required before HRV monitoring can be
recommended with a high degree of confidence for hypercapnia early detection
monitoring in real-life environments. Additionally, HRV monitoring would have to be
studied in symptomatic patients in comparison to standard EtCO2 monitoring to see if
HRV can accurately predict symptom onset as efficiently as standard EtCO 2 monitoring.
That being said, if further experimentation confirms the provocative results reported
here, there is significant potential for use in hospitals, outpatient surgery centers, first
responder units, and pulmonary centers to monitor for symptoms associated with
elevated levels of CO2 in real time without the need for costly and timely arterial blood
gas panels and EtCO2 monitoring devices. Additionally, divers using rebreathers could
benefit with real-time hypercapnia pre-detection. A waterproof version of the proposed
device could be fitted to a diver’s suit and be effective at biometric monitoring both by
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the diver and by a surface crew in training scenarios, thereby significantly increasing the
overall diver’s safety and training.
4.2 Conclusion
Our initial clinical research cohort study demonstrated that HRV monitoring is
reproducible in our study group, did show a statistically significant change in response
to elevated inspired CO2, and correlates with EtCO2 monitoring. Our novel HRV
methodology and algorithm can be easily added via software upgrades to any current
ECG monitoring machines, or manufactured as a stand-alone ECG/HRV monitoring
device. This type of monitoring can inexpensively reduce the need for additional, more
expensive EtCO2 monitoring devices and/or arterial blood gas analysis. We further
propose that HRV analysis can provide an early warning system to detect hypercapnia
related symptomatology prior to escalation of symptoms to a detrimental level and
perhaps irreversible states in a number of health-related physiological stress scenarios
and disease conditions.
4.3 Conclusions and Follow-on-Work
Follow-up research for this project would include development and testing of a
more robust system which would be waterproof and incorporated into a smaller device
that would integrate seamlessly with diving equipment or other medical monitoring and
diagnosis systems. The next-generation system would have to accurately deal with
additional parameters and factors such as sex, nicotine intake, caffeine intake, over-thecounter drugs, prescription drugs, hormone levels, the presence of oxidative stress,
age, body mass index, depression, physiological stress, physical activity and possibly
race. Additionally, further work and more testing needs to be done with a larger subject
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group to incorporate and deal with the measurement noise that electromyography has
on an ECG. A new more advanced system would need to have a learning algorithm
which could learn the differences between each individual’s change in physical activity,
which can reduce the HRV, as well as take into account stress on the ANS that is
reducing the HRV. Furthermore, a concerted effort should be made to determine if the
curved peak of a PPG could accurately determine HRV. This would allow incorporation
into a smaller ring device or a device which shines an infrared light on the part of the ear
between the concha and the antitragus in the area of the lower part of the ear. This is
common for Special Operations operators to wear earbuds, and much of the general
population wears earbuds regularly, making it an easy place to sense for HRV. It is
apparent that the blood moves well in and out of these ear-related areas so those
locations may be a good candidate site for tracking heart rate and changes in HRV.
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APPENDIX A: DITURI COMPUTER PROGRAM
GUI imports
import matplotlib
matplotlib.use("TkAgg")
from matplotlib.backends.backend_tkagg import FigureCanvasTkAgg,
NavigationToolbar2TkAgg
from matplotlib.figure import Figure
import matplotlib.animation as animation
from matplotlib import style
import Tkinter as tk
import numpy as np
from sklearn.neighbors import LocalOutlierFactor
# Imports for serial port
import serial
import Queue
import threading
import atexit
import copy
import time
# SERIAL PORT USED
COM_PORT = 'COM6'
# Set some styles
LARGE_FONT= ("Verdana", 12)
style.use("ggplot")
fig = Figure(figsize=(5,5), dpi=100)
axes = fig.add_subplot(111)
hl = []
program_is_running = True
no_plot_yet = True
first_r_time = True
N_VALUES_TO_SAVE = int(((10*60000)/200))
N_VALUES_TO_PLOT = 150
N_MIN_VALUES = 10
N_MIN_OUTLIER_VALUES = 10 # Minimum values to start calculation of outliers
rr_times = np.zeros((N_VALUES_TO_SAVE))
r_timek = long()
r_timek_1 = long()
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rr_k = 0.0
rr_k_1 = 0.0
ellipse = np.zeros((N_VALUES_TO_SAVE,2))
start_idx = 0
end_idx = 1
# Calculate the ratio of the axis of the ellipses for the time_min
def time_average_rr_ratio(time_min, rr_times, start_idx, end_idx):
time_ms = time_min*60000.0 # Minutes to ms conversion
# Construct linear array
if start_idx > end_idx:
rr_data = np.concatenate((rr_times[start_idx:], rr_times[0:end_idx+1]), axis = 0)
else:
rr_data = rr_times[start_idx:end_idx+1]
time_data = rr_data[-1] - rr_data
start_time_idx = np.argwhere( time_data > time_ms)
if time_ms == 0.0:
# Calculate the full RR ratio
rr_periods = np.diff(rr_data)
n = len(rr_periods)
#print('window: {}; nValues: {}'.format(time_min, n))
#print(start_time_idx)
if n > N_MIN_VALUES:
# fit the outlier model
clf = LocalOutlierFactor(n_neighbors = N_MIN_VALUES)
y_pred = clf.fit_predict(rr_periods.reshape(-1,1))
inliers_idx = np.argwhere(y_pred > 0)
outliers_idx = np.argwhere(y_pred < 0)
rr_periods = rr_periods[inliers_idx]
# Parameters of the ellipse
n = len(rr_periods)
xs = rr_periods[0:n-2]
ys = rr_periods[1:n-1]
n = len(xs)
xc = np.mean(xs)
yc = np.mean(ys)
# Standard deviations from l1 and l2
'''See: Geometry of the Poincare plot of RR intervals and its
asymmetry in healthy adults
'''
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SD1C = np.sqrt(
(1.0/(2.0*n))*np.sum(np.square((xs - ys) - (xc - yc))))
SD2C = np.sqrt(
(1.0/(2.0*n))*np.sum(np.square((xs + ys) - (xc + yc))))
# Standard deviation of the short axis of the ellipse to
# the standard deviation of thelong axis of the ellipse
ratio = SD2C/SD1C
return ratio
else:
return -1
else:
# Check if enough time has passed to compute the require factor
if np.shape(start_time_idx)[0] > 0:
rr_periods = np.diff(rr_data[start_time_idx[-1,0]:-1])
n = len(rr_periods)
#print('window: {}; nValues: {}'.format(time_min, n))
#print('start_time_idx: {}\n'.format(start_time_idx[0,0]))
#print(start_time_idx[-1,0])
if n > N_MIN_VALUES:
# fit the outlier model
clf = LocalOutlierFactor(n_neighbors = N_MIN_VALUES)
y_pred = clf.fit_predict(rr_periods.reshape(-1,1))
inliers_idx = np.argwhere(y_pred > 0)
outliers_idx = np.argwhere(y_pred < 0)
rr_periods = rr_periods[inliers_idx]
# Parameters of the ellipse
n = len(rr_periods)
xs = rr_periods[0:n-2]
ys = rr_periods[1:n-1]
n = len(xs)
xc = np.mean(xs)
yc = np.mean(ys)
# Standard deviations from l1 and l2
'''See: Geometry of the Poincare plot of RR intervals and its
asymmetry in healthy adults
'''
SD1C = np.sqrt(
(1.0/(2.0*n))*np.sum(np.square((xs - ys) - (xc - yc))))
SD2C = np.sqrt(
(1.0/(2.0*n))*np.sum(np.square((xs + ys) - (xc + yc))))
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# Standard deviation of the short axis of the ellipse to
# the standard deviation of thelong axis of the ellipse
ratio = SD2C/SD1C
return ratio
else:
return -1
else:
return -1
def update_plot(i):
global hl, axes
global start_idx, end_idx, ellipse
global no_plot_yet
# Calculate index extents
n_first_values = end_idx + 1
if start_idx > end_idx:
if n_first_values > N_VALUES_TO_PLOT:
plot_data = ellipse[end_idx - N_VALUES_TO_PLOT:end_idx + 1,:]
else:
plot_data = np.concatenate((ellipse[start_idx:,:],
ellipse[0:n_first_values,:]), axis = 0)
else:
if n_first_values > N_VALUES_TO_PLOT:
plot_data = ellipse[end_idx - N_VALUES_TO_PLOT:end_idx + 1,:]
else:
plot_data = ellipse[0:end_idx + 1,:]
# fit the outlier model for ploting
#print('plot_data shape (before): {}'.format(np.shape(plot_data)))
if np.shape(plot_data)[0] > N_MIN_VALUES:
clf = LocalOutlierFactor(n_neighbors = N_MIN_VALUES)
y_pred = clf.fit_predict(plot_data)
inliers_idx = np.argwhere(y_pred > 0)
outliers_idx = np.argwhere(y_pred < 0)
plot_data = plot_data[inliers_idx[:,0],:]
#print('inliers_idx shape: {}'.format(np.shape(inliers_idx)))
#print('plot_data shape: {}'.format(np.shape(plot_data)))
# Check if this is the first time to plot
if no_plot_yet:
#hl, = axes.plot(plot_data[:,0], plot_data[:,1], 'ro')
hl, = axes.plot(plot_data[:,0], plot_data[:,1], color = 'red', linestyle = 'None', alpha =
0.5,
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marker = 'o', markeredgecolor = 'black', markersize = 5)
#hl, = axes.scatter(plot_data[:,0], plot_data[:,1], color = 'red',edgecolor='k', size =
20)
axes.set_xlabel(r'$R_{k}$ (ms)')
axes.set_ylabel(r'$R_{k-1}$ (ms)')
no_plot_yet = False
else:
hl.set_xdata(plot_data[:,0])
hl.set_ydata(plot_data[:,1])
# Set axis limits
axes.set_xlim([650, 1300])
axes.set_ylim([650, 1300])
def get_custom_time_window(event):
global rrCustomTimeWindow
print('Value entered: {}'.format(e1.get()))
try:
rrCustomTimeWindow = float(e1.get())
label_rrCustomTitle.configure(text = "RR Custom: " + str(rrCustomTimeWindow) +
" min")
except ValueError:
label_rrCustomTitle.configure(text = "RR Custom: NOT VALID!, usign 1 min")
rrCustomTimeWindow = 1.0
#---------------------------------------------------------------------# Create window layout
# Create root window
root = tk.Tk()
root.title('RR Analysis')
# Create two frames
frame_left = tk.Frame(root) # Contains the RR plot
frame_right = tk.Frame(root) # Contains the indicators
frame_left.pack(side=tk.LEFT, fill=tk.BOTH, expand=True)
frame_right.pack(side=tk.RIGHT, fill=tk.BOTH, expand=True)
# Place plot title on left frame
msg_title = tk.Message(frame_left, text = 'RR Plot')
msg_title.config(bg = 'white', font = ('times',24,'italic'), width = 400)
msg_title.pack()
# Create canvas for plot
canvas = FigureCanvasTkAgg(fig, master = frame_left)
canvas.show()
#canvas.get_tk_widget().grid(row = 1, column = 0)
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canvas.get_tk_widget().pack(side=tk.BOTTOM, fill=tk.BOTH, expand=True)
toolbar = NavigationToolbar2TkAgg(canvas, frame_left)
toolbar.update()
canvas._tkcanvas.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
# Place indicators on right frame
label_rr1minTitle = tk.Label(frame_right, text = 'RR: 1 min',\
relief = 'ridge', width=15)
label_rr1minTitle.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
rr1minValueDouble = np.nan
rr1minValueString = tk.StringVar()
rr1minValueString.set('-')
msg_rr1minValue = tk.Message(frame_right, textvariable = rr1minValueString)
msg_rr1minValue.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
label_rr5minTitle = tk.Label(frame_right, text = 'RR: 5 min',\
relief = 'ridge', width=15)
label_rr5minTitle.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
rr5minValueDouble = np.nan
rr5minValueString = tk.StringVar()
rr5minValueString.set('-')
msg_rr5minValue = tk.Message(frame_right, textvariable = rr5minValueString)
msg_rr5minValue.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
label_rr10minTitle = tk.Label(frame_right, text = 'RR: 10 min',\
relief = 'ridge', width=15)
label_rr10minTitle.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
rr10minValueDouble = np.nan
rr10minValueString = tk.StringVar()
rr10minValueString.set('-')
msg_rr10minValue = tk.Message(frame_right, textvariable = rr10minValueString)
msg_rr10minValue.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
label_rrFullTitle = tk.Label(frame_right, text = 'RR: Full',\
relief = 'ridge', width=15)
label_rrFullTitle.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
rrFullValueDouble = np.nan
rrFullValueString = tk.StringVar()
rrFullValueString.set('-')
msg_rrFullValue = tk.Message(frame_right, textvariable = rrFullValueString)
msg_rrFullValue.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
label_rrCustomTitle = tk.Label(frame_right, text = 'RR: Custom 1 min',\
relief = 'ridge', width=15)
label_rrCustomTitle.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
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# Create an entry for the custom RR ratio time window
e1 = tk.Entry(frame_right)
e1.bind("<Return>", get_custom_time_window)
e1.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
rrCustomTimeWindow = 1.0
rrCustomValueDouble = np.nan
rrCustomValueString = tk.StringVar()
rrCustomValueString.set('-')
msg_rrCustomValue = tk.Message(frame_right, textvariable = rrCustomValueString)
msg_rrCustomValue.pack(side=tk.TOP, fill=tk.BOTH, expand=True)
#-------------------------------------------------------------# Create threads for serial port and for updating the plot
queue = Queue.Queue(100)
# This read each line arrived from the serial port
def serial_read(ser):
global program_is_running, queue
# Verify the port is available
ser.baudrate = 9600
ser.port = COM_PORT
ser.timeout = 1
ser.open() # Open serial port. CATCH EXCEPTION
while program_is_running: # While serial port is opened
line = ser.readline()
if line != '':
queue.put(line)
ser.close()
print('Ending thread: serial_read\n')
# This extracts the R time from each line arrived from the serial port
def calculate_rr():
global rr1minValueString, queue, k
global r_timek, r_timek_1, rr_k, rr_k_1, rr_intervals
global k, xList, yList, hl, axes, start_idx, end_idx
global rr_times, first_r_time
while program_is_running: # While program is running
line = queue.get(block = True)#, timeout = None)
if (line != '') and (line != 'EndThread'):
# Update values
s, r_time = line.split(',')
r_timek = float(r_time)
if first_r_time: # Check if this is the first time
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rr_times[0] = r_timek
rr_k = 0.0
rr_k_1 = 0.0 # r_time
first_r_time = False
else:
rr_k = float((r_timek - r_timek_1))
#rr_intervals[end_idx] = rr_k
rr_times[end_idx] = r_timek
ellipse[end_idx,:] = np.array([rr_k, rr_k_1])
rr1minValueDouble = time_average_rr_ratio(1.0, rr_times, start_idx, end_idx)
if rr1minValueDouble != -1:
string = '{:.2f}'.format(rr1minValueDouble)
rr1minValueString.set(string)
else:
rr1minValueString.set('-')
rr5minValueDouble = time_average_rr_ratio(5.0, rr_times, start_idx, end_idx)
if rr5minValueDouble != -1:
string = '{:.2f}'.format(rr5minValueDouble)
rr5minValueString.set(string)
else:
rr5minValueString.set('-')
rr10minValueDouble = time_average_rr_ratio(10.0, rr_times, start_idx, end_idx)
if rr10minValueDouble != -1:
string = '{:.2f}'.format(rr10minValueDouble)
rr10minValueString.set(string)
else:
rr10minValueString.set('-')
rrFullValueDouble = time_average_rr_ratio(0.0, rr_times, start_idx, end_idx)
if rrFullValueDouble != -1:
string = '{:.2f}'.format(rrFullValueDouble)
rrFullValueString.set(string)
else:
rrFullValueString.set('-')
rrCustomValueDouble = time_average_rr_ratio(rrCustomTimeWindow, rr_times,
start_idx, end_idx)
if rrCustomValueDouble != -1:
string = '{:.2f}'.format(rrCustomValueDouble)
rrCustomValueString.set(string)
else:
rrCustomValueString.set('-')
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# Update the indices of the circular buffer
if end_idx >= start_idx:
end_idx = end_idx + 1
else:
end_idx = end_idx + 1
start_idx = start_idx + 1
if end_idx == N_VALUES_TO_SAVE-1:
end_idx = 0
start_idx = 1
# Update variables for the next iteration
r_timek_1 = r_timek
rr_k_1 = rr_k
#print('time (ms) = {}'.format(r_timek))
print('Ending thread: print_line\n')
def on_closing(serial_port_handle):
global program_is_running, queue
program_is_running = False
serial_port_handle.cancel_read()
queue.put('EndThread') # Put empty line to unblock thread
time.sleep(1)
root.destroy()
# Create serial port object
serial0 = serial.Serial()
# Star threads
thread1 = threading.Thread(target=serial_read, args = (serial0,)).start()#, args =
(serial0,)).start()
thread2 = threading.Thread(target=calculate_rr).start()
# Setup the updating screen
ani = animation.FuncAnimation(fig, update_plot, interval = 300)
root.protocol("WM_DELETE_WINDOW", lambda arg0 = serial0: on_closing(arg0)) #
Closing actions
root.mainloop()
'''cd "C:\Users\dituri\Documents\PythonCode\ecg_project"
python rr_analysis_f_v1.py'''
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APPENDIX B: GLOSSARY OF TERMS
ABG – Arterial Blood Gas
ADC – Analog-to-digital converter
ANS – Autonomic Nervous System
APPS – Applications
BMI – Body Mass Index
CCR – Closed Circuit Rebreather
CNS – Central Nervous System
CO2 – Carbon Dioxide
COPD – Chronic Obstructive Pulmonary Disease
CPR – Cardiopulmonary Resuscitation
DIN – Deutsches Institut für Normung
Dead air space – volume of air which is inhaled that does not take part in the gas
exchange.
ECG – Electro Cardiogram
FPU – Floating-point Unit
HF – High Frequency
HRV – Heart Rate Variability
IRB – Institutional Review Board
LED – Light Emitting Diode
LF – Low Frequency
LF/HF – Low Frequency Divided by High Frequency
MCU – Microcontroller unit
O2 – Oxygen
OTC – Over the Counter
Poincaré plot – Return map plot popularized by Poincare.
PPG – Photoplethysmography
PSI – Pounds per Square Inch
PaCO2 – Carbon dioxide arterial pressure
Rebreather – Recirculation device
RR – Distance from the R of the QRS complex to next R
SD – Standard Deviation
SD1 – Proposed short side of the HRV Poincaré plot ellipse
SD2 – Proposed longer side of the HRV Poincaré plot ellipse
SCUBA – Self Contained Underwater breathing Apparatus
SCR – Semi-Closed Rebreather
SPI – Serial Peripheral Interface
TFT LCD – Thin-film-transistor liquid-crystal display
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APPENDIX C: INFORMED CONSENT FORM
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APPENDIX D: DAILY FOOD LOG

Daily food / drink / supplement diary
If you put it in your body in any way, please note it on this sheet for 48 hours
prior to the study.
Your study date is _________________.
Start your log on _________________.
Item

Time / Date

Approximate Quantity
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APPENDIX E: DATA COLLECTION SHEETS
The following information will be digitally recorded by the devices supplied:
ETCO2 Digital
Video / Audio
Entire cardiac rhythm digitally (This will be converted into HRV, QRS and any other data required)
+2 Min

+4 Min

+6 min

+8 min

+10 min

+12 min

+14 Min

+16 Min

+18 Min

+20 Min

BP
GO /
NO GO

Physical examination General format
Age _____ Height ______ Weight _____
GENERAL APPEARANCE: The patient is alert and oriented and in no acute distress.
VITALS SIGNS: Temperature _____, pulse ___, respirations ____, and blood pressure is ____.
HEENT: Head is normocephalic with normal hair distribution. No evidence of trauma. Ears: No acute purulent
discharge. Eyes: Conjunctivae pink with no scleral jaundice. Nose: Normal mucosa and septum.
NECK: Supple with no cervical or supraclavicular lymphadenopathy. Trachea is midline. Thyroid: Not palpable.
LUNGS: Normal symmetrical expansion of both hemithoraces. Coarse breath sounds with some rhonchi.
HEART: S1 and S2 normal.
ABDOMEN: Soft.
EXTREMITIES: No swelling or effusion in any of the joints of the hands or feet. No peripheral edema.
SKIN: Normal color, turgor and temperature. No ulcerations or rashes noted.
LYMPHATICS: No cervical or supraclavicular lymphadenopathy. .
NEUROLOGICAL: Alert and oriented. GCS is ____.
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Pain Areas - Shade with XX s
Numbness- Shade with /////// s

Neurological checklist
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APPENDIX F: IRB APPROVAL
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